Shanghai Pharmaceuticals Holding Co.,Ltd.’s Net Profit Dropped 35.6% in First Quarter of 2022

Shanghai Pharmaceuticals Holding Co.,Ltd. (上海医药集团股份有限公司) (601607.SH) reported a net profit of 1.5 billion yuan in the first quarter of 2022, down 35.6% year-on-year.

Meanwhile, the company posted 56.9 billion yuan in revenue, up 10.3% year-on-year.

At the end of the reporting period, it had 182 billion yuan in total assets and 107.6 billion yuan in total liabilities, with a liability-to-asset ratio of 59.1%.